Scott Allen Armstrong
Affiliations: | Biology, Molecular and Cellular | Harvard University, Cambridge, MA, United States |
Area:
General Biology, Molecular Biology, Biochemistry, OncologyWebsite:
https://hsci.harvard.edu/people/scott-armstrong-md-phdGoogle:
"Scott Allen Armstrong"Bio:
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Michael Stuart Brown | grad student | 1994 | UT Southwestern | |
| (Molecular and biochemical characterization of Rab geranylgeranyl transferase.) | ||||
| Joseph L. Goldstein | grad student | 1994 | UT Southwestern | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gu H, Chen C, Hou ZS, et al. (2024) PI3Kγ maintains the self-renewal of acute myeloid leukemia stem cells by regulating the pentose phosphate pathway. Blood |
| Tubío-Santamaría N, Jayavelu AK, Schnoeder TM, et al. (2023) Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia. Molecular Cancer. 22: 196 |
| Issa GC, Aldoss I, DiPersio J, et al. (2023) The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature |
| Uckelmann HJ, Haarer EL, Takeda R, et al. (2022) Mutant NPM1 directly regulates oncogenic transcription in acute myeloid leukemia. Cancer Discovery |
| Soto-Feliciano YM, Sanchez-Rivera FJ, Perner F, et al. (2022) A molecular switch between mammalian MLL complexes dictates response to Menin-MLL inhibition. Cancer Discovery |
| Aubrey BJ, Cutler JA, Bourgeois W, et al. (2022) IKAROS and MENIN coordinate therapeutically actionable leukemogenic gene expression in MLL-r acute myeloid leukemia. Nature Cancer |
| Heikamp EB, Henrich JA, Perner F, et al. (2021) The Menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML. Blood |
| Perner F, Schnoeder TM, Xiong Y, et al. (2021) YBX1 mediates translation of oncogenic transcripts to control cell competition in AML. Leukemia |
| Cai SF, Chu SH, Goldberg AD, et al. (2020) Leukemia cell of origin influences apoptotic priming and sensitivity to LSD1 inhibition. Cancer Discovery |
| Dzama MM, Steiner M, Rausch J, et al. (2020) Synergistic Targeting of FLT3 Mutations in AML via Combined Menin-MLL and FLT3 Inhibition. Blood |